Pharmacoeconomic Analysis and Treatment Pattern in Sepsis Patients: A Cross-sectional Prospective and Retrospective Study

Published on:June 2019
Indian Journal of Pharmacy Practice, 2019; 12(2):84-91
Research Article | doi:10.5530/ijopp.12.2.20


Pharmacoeconomic Analysis and Treatment Pattern in Sepsis Patients: A Cross-sectional Prospective and Retrospective Study


Authors and affiliation (s):

Maneesha Erraboina1, Karthik Gopagoni1, Abhilash Manthen1, Sangram Vurumadla2, Suresh Bandari3,*

1Department of Pharmacy Practice, Rohini Superspeciality Hospitals and St. Peter’s Institute of Pharmaceutical Sciences, Hanamkonda, Warangal, Telangana, INDIA.

2Department of Pharmacy Practice, St. Peter’s Institute of Pharmaceutical Sciences, Hanamkonda, Warangal, Telangana, INDIA.

3Department of Pharmaceutics, St. Peter’s Institute of Pharmaceutical Sciences, Hanamkonda, Warangal, Telangana, INDIA.

Abstract:

Objectives: Increasing health care cost is a major concern in the developing world and has increased the economic burden for a common man. Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. The study objective is to describe and appraise the pattern of antibiotics prescribing based on the blood culture report and to evaluate the cost analysis in sepsis patients. Methods: A retrospective and prospective analysis was conducted at tertiary care hospitals, Warangal. The follow up was done for all patients enrolled in the study. Antibiotic-prescription pattern in both blood culture positive and negative were analyzed and compared. The data collection comprises the direct medical and non-medical cost, cost of medications prescribed during the therapy and while discharge. Results: A combined analysis of antibiotic pattern and cost of treatment was performed. The most commonly prescribed antibiotics were Piperacillin + Tazobactum, Vancomycin, Clindamycin, Tobramycin, Cefpodoxime, Meropenem and Imipenam. The cost for blood culture positive patients was 35,920 ± 15,292 rupees and blood culture negative patients was 18,082 ± 7,987 rupees. The blood culture and sensitivity testing was carried out and the common organisms isolated were Escherichia coli and Klebsiella pneumoniae. The overall cost of Klebsiella pneumoniae patients (Rs.35,688 ± 15,162) was higher than the Escherichia coli (Rs.24,767 ± 15,498). The dissimilarity in the cost of therapy may be due to change of treatment site. Conclusion: The present study infers that treatment pattern of antibiotics varied based on the blood culture report of an individual patient; for majority cohort piperacillin + tazobactum was the drug of choice for both blood culture positive and negative sepsis patients. On the basis of current cost analysis data, the treatment cost of blood culture positive patients is significantly high than that of blood culture negative patients.

Key words: Sepsis, Pharmacoeconomic analysis, Treatment pattern, Antibiotics, Direct medical cost, Direct non-medical cost.




 

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.

DOI HISTORY

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs